APA (7th ed.) Citation

Notcutt, W., Langford, R., Davies, P., Ratcliffe, S., & Potts, R. (2012). A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols). Multiple sclerosis, 18(2), 219-228. https://doi.org/10.1177/1352458511419700

Chicago Style (17th ed.) Citation

Notcutt, W., R. Langford, P. Davies, S. Ratcliffe, and R. Potts. "A Placebo-controlled, Parallel-group, Randomized Withdrawal Study of Subjects with Symptoms of Spasticity Due to Multiple Sclerosis Who Are Receiving Long-term Sativex® (nabiximols)." Multiple Sclerosis 18, no. 2 (2012): 219-228. https://doi.org/10.1177/1352458511419700.

MLA (9th ed.) Citation

Notcutt, W., et al. "A Placebo-controlled, Parallel-group, Randomized Withdrawal Study of Subjects with Symptoms of Spasticity Due to Multiple Sclerosis Who Are Receiving Long-term Sativex® (nabiximols)." Multiple Sclerosis, vol. 18, no. 2, 2012, pp. 219-228, https://doi.org/10.1177/1352458511419700.